Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TONMYA PK in Elderly vs Non-Elderly
NCT07413367Phase 1Active, not recruiting
- Sponsor
- Tonix Pharmaceuticals
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of Tonmya in fibromyalgia (FM) (2 arms), sponsored by Tonix Pharmaceuticals. Primary endpoints: Area Under the curve from time zero to infinity at 16 days, Area Under the Curve from time zero to the last measurable concentration at 16 days and 1 more. Started Dec 2025; status: active, not recruiting.
02
Drugs
Tonmya
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT07413367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07413367.